
Genome Project Aims at Better Healthcare for Black Canadians
Feb 10, 2026 · Genome Canada has launched the genCARE project, which aims to improve health outcomes for Black Canadians by uncovering genetic variants unique to that population.
FDA OKs Deutetrabenazine (Austedo) for Tardive Dyskinesia
Aug 30, 2017 · The US Food and Drug Administration (FDA) has approved deutetrabenazine (Austedo, Teva) for the treatment of tardive dyskinesia in adults. Deutetrabenazine, a deuterated form of the …
France Bets on Medical AI, to Train 100,000 Doctors Yearly
Feb 23, 2025 · With AI becoming a core part of medical education and clinical practice, France is rolling out an AI roadmap to modernise hospitals, train doctors, and ensure ethical AI use in patient care.
Is CBD Effective for Psychosis? New Study Aims to Find Out
Feb 18, 2025 · CBD has shown promise as a treatment for psychosis in small studies and case reports. A large, international trial launching in April aims to put those findings to the test.
The Knowledge of Effective Parenting Scale (KEPS) - Medscape
How well do most parents understand the various stages of child development and how does that knowledge help them with their parenting skills?
Q&A: Tardive Dyskinesia -- Prevention and Treatment - Medscape
Jun 27, 2024 · While I don't routinely use scales in my practice, I have used the AIMS (Abnormal Involuntary Movement Scale) in clinical studies and for drug authorization purposes.
Stem Cell 'Robot' Could Transform Cell Therapies - Medscape
Mar 17, 2023 · The UK stem cell bank aims to test the robot over a 12-month period to see whether the cells produced by the fully automated system meet the standards needed for them to be used in the …
Scoring System Could Mean Better Access to Lung Transplant
Scoring system could improve access for hard-to-match candidates due to height and blood type.
Why Is Oropouche Spreading so Fast? - Medscape
May 19, 2025 · The Oropouche virus is spreading fast across the Americas, driven by climate change and deforestation — raising alarms over a new global arboviral threat.
EMA Refuses Marketing Authorization for Alzheimer's Drug
Jul 26, 2024 · The main measure of effectiveness was a change in symptoms after 18 months, measured using the Clinical Dementia Rating–Sum of Boxes (CDR-SB) scale for assessing the …